Storia in 2 fonti

Certara accelerates drug discovery with Nvidia BioNeMo toolkit as AI reshapes pharma R&D

Nvidia launches BioNeMo Agent Toolkit for AI-driven drug discovery. Certara integrates the suite as 50-plus companies adopt it, boosting GPU compute demand.

Raccontata da

cryptobriefing.com

benzinga.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

cryptobriefing.comStai leggendo1 mese fa

Certara accelerates drug discovery with Nvidia BioNeMo toolkit as AI reshapes pharma R&D

Nvidia launches BioNeMo Agent Toolkit for AI-driven drug discovery. Certara integrates the suite as 50-plus companies adopt it, boosting GPU compute demand.

originale

benzinga.com1 mese fa

Nvidia Powers AI Agent Strategies for Certara, Silo Pharma - NVIDIA (NASDAQ:NVDA)

Nvidia expands its life sciences AI ecosystem through a Certara partnership and QwikAgents' entry into its developer program.

Leggi questa versione → originale

Timeline cronologica

martedì 7 luglio 2026·cryptobriefing.com
Certara accelerates drug discovery with Nvidia BioNeMo toolkit as AI reshapes pharma R&D
Nvidia launches BioNeMo Agent Toolkit for AI-driven drug discovery. Certara integrates the suite as 50-plus companies adopt it, boosting GPU compute demand.
martedì 7 luglio 2026·benzinga.com
Nvidia Powers AI Agent Strategies for Certara, Silo Pharma - NVIDIA (NASDAQ:NVDA)
Nvidia expands its life sciences AI ecosystem through a Certara partnership and QwikAgents' entry into its developer program.